Reveals the list of the top ten circulating shareholders of 400 listed companies, "buying up" hundreds of ETFs, with long-term funds taking a dual approach to increase equity assets.

As the annual reports of A-share listed companies and public mutual funds are gradually disclosed in 2025, the holdings of long-term funds such as social security funds, QFII, and enterprise annuities have been revealed.
From the perspective of allocation, long-term funds are not only buying leading stocks in high-end manufacturing, pharmaceuticals, and chemicals but also “sweeping” numerous broad-based ETFs and growth-style thematic ETFs, deploying equity assets through a dual approach.
A review of the disclosed annual reports of listed companies shows that as of April 7, social security funds, QFII, and enterprise annuities appeared in the top ten circulating shareholders of 400 A-share listed companies.
In terms of long-term fund holdings, they are mainly distributed across sectors such as high-end manufacturing, pharmaceuticals, non-ferrous metals, and chemicals.
Specifically, in the high-end manufacturing sector, including Zhejiang Liming, Zhongchao Holdings, Yunda Shares, Sany Heavy Industry, Xingwang Ruijie, Hongfa Shares, and others.
In the pharmaceuticals and biotech sector, long-term funds hold stocks such as China National Pharmaceutical Group, Mindray Medical, Tigermed, Watson Bio, and Lizhu Group.
The chemical sector also attracts high attention.
In the top ten circulating shareholders of industry leaders like Satellite Chemical, Wanwei High-tech, Huafeng Chemical, and Hualu Hengsheng, long-term fund presence is frequently observed.
Additionally, non-ferrous metal targets such as Yunnan Copper, Jiangxi Copper, Yun Aluminum, and Jinmiao Shares are also held by long-term funds.
It is worth noting that some secondary new stocks are also held collectively by long-term funds.
(Shanghai Securities News)